(RTTNews) - Biopharmaceutical company Ligand Pharmaceuticals, Inc. (LGND), while reporting a loss in its fourth quarter, compared to prior year's profit, on Thursday confirmed fiscal 2025 forecast.
Get Instant Summarized Text (Gist) A platform combining synthetic biology and nanotechnology has been repurposed for ultrasensitive water contamination detection. It uses nanomechanical ...
School of Agricultural Engineering, Jiangsu University, Zhenjiang 212013, PR China School of Chemistry and Chemical Engineering, Jiangsu University, Zhenjiang 212013, PR China Key Laboratory of ...
You may wonder how to lose water weight if you have excess fluid retention and swelling. Cutting down on salty and sugary foods, drinking plenty of water, getting enough sleep, and staying ...
Department of Chemistry, Engineering Research Center of Advanced Rare Earth Materials (Ministry of Education), Tsinghua University, Beijing 100084, People’s Republic of China Department of Chemistry, ...
Water poured over the tracks from the nearby Neponset River just after 7:30 a.m., surrounding a Mattapan Line trolley car with six passengers and an operator aboard, a spokesperson for the transit ...
Courtney Di Vittorio receives funding from the North Carolina Attorney General's Office Environmental Enhancement Grant Program (award WFU021PRE1) to collect data at High Rock Lake, NC. She is ...
This water, now over 4.5 billion years old, has been perpetually renewed through Earth's water cycle. My research team has recently proposed a new theory to explain how water first arrived on Earth.
In this perspective, the role of one of these proinflammatory proteins, referred to as P-selectin glycoprotein ligand (PSGL)-1, is of particular interest. Indeed, contemporary evidence points to the ...
In summary, an Fe complex with DPA-Bpy as the ligand was synthesized, and it shows obvious cytotoxicity on proliferation of HeLa cells. The IC 50 of the Fe complex and its HSA complex adduct is 1.18 ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results